| 000 | 01497 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513131004.0 | ||
| 264 | 0 | _c19971125 | |
| 008 | 199711s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/89.21.1566 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aReggy, A A | |
| 245 | 0 | 0 |
_aUsing 3'-azido-2',3'-dideoxythymidine (AZT) to prevent perinatal human immunodeficiency virus transmission and risk of transplacental carcinogenesis. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cNov 1997 |
||
| 300 |
_a1566-7 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinogens _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInfectious Disease Transmission, Vertical _xprevention & control |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNational Institutes of Health (U.S.) |
| 650 | 0 | 4 | _aPlacenta |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Complications, Infectious |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aZidovudine _xadministration & dosage |
| 700 | 1 | _aRogers, M F | |
| 700 | 1 | _aSimonds, R J | |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 89 _gno. 21 _gp. 1566-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/89.21.1566 _zAvailable from publisher's website |
| 999 |
_c9332115 _d9332115 |
||